Study of Oral Papillomavirus In Teens and Twenties
NCT00994019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2020-01-09
Summary
Recently human papillomavirus (HPV) has been recognized to cause some oropharyngeal (tonsil) cancer. But very little is known about oral HPV infection and risk factors. This study will evaluate how common oral HPV infection is, what sexual behaviors are associated with risk for infection, and how long infections tend to last.
Conditions
- STD
Sponsors & Collaborators
-
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Gypsyamber D'Souza, PhD · Johns Hopkins Bloomberg School of Public Health
Eligibility
- Min Age
- 18 Years
- Max Age
- 26 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
The SPOT-HPV Study
NCT05524025 ·Status: COMPLETED
-
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
NCT03501992 ·Status: COMPLETED ·Phase: NA
-
4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
NCT01995721 ·Status: UNKNOWN ·Phase: PHASE3
-
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
NCT02188004 ·Status: COMPLETED
-
Low Dose Cyclophosphamide Treats Genital Warts
NCT00999986 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers
NCT03912831 ·Status: TERMINATED ·Phase: PHASE1
-
Zinc Sulfate for Human Papillomavirus (HPV)
NCT03404310 ·Status: TERMINATED ·Phase: NA
-
Dynamics of Human PApilloma Virus Interactions; Internet-based Students HeAlth Research Enterprise
NCT01988948 ·Status: COMPLETED ·Phase: NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
NCT06587243 ·Status: RECRUITING ·Phase: NA
-
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
NCT02689726 ·Status: TERMINATED ·Phase: PHASE1
-
The STOP-HPV Scale Up Study
NCT06831383 ·Status: RECRUITING ·Phase: NA
-
Safety Study of Multikine in the Treatment of Perianal Warts
NCT02115919 ·Status: TERMINATED ·Phase: PHASE1
-
Study of FluBHPVE6E7 in HPV-16 Infected Women
NCT04490512 ·Status: COMPLETED ·Phase: PHASE1
-
Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)
NCT05649865 ·Status: RECRUITING
-
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
NCT05584332 ·Status: TERMINATED ·Phase: PHASE3
-
Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
NCT00851643 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Imiquimod Treatment of Oral Dysplasia
NCT07210775 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Multi-level School-based Intervention to Improve HPV Vaccine Uptake and Completion in South Africa
NCT05919901 ·Status: SUSPENDED ·Phase: NA
-
High and Low Resource Interventions to Promote HPV Vaccines
NCT03824093 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
NCT06465914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
NCT02379520 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
NCT00941889 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*
NCT07339163 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama
NCT04604743 ·Status: WITHDRAWN ·Phase: NA
-
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
NCT03911076 ·Status: TERMINATED ·Phase: PHASE2